Rapporten
Dybdegående analyser af virksomhedsfinansiering, vækststrategier og markedsindsigt fra verdens mest innovative virksomheder
2 rapporter og tæller
Opdateret dagligt med den seneste markedsintelligens
Fundraising
Evommune
Evommune Raises $50M in Series B
Evommune, a HealthTech company based in Cambridge, MA, has raised $50M in Series B at a $300M valuation led by Arix Bioscience, EQT Life Sciences.
Fundraising News Team
Aug 1, 2025
0 min read
HealthTech
Evommune
Evommune raises $50M Series B at $300M valuation
Evommune raises $50M in Series B at $300M valuation. Oral immunology treatments...
Editorial Team
Aug 1, 2025
0 min read•$50M
Side 1
Viser 2 rapporter • Side 1 • Kategori: all
Hold dig foran markedet
Få ugentlig indsigt leveret til din indbakke. Ingen spam, kun intelligens.